First randomized clinical trial finds no harm from population screening for dementia

First randomized clinical trial finds no harm from population screening for dementia

First randomized clinical trial finds no harm from population screening for dementia

Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia.